Inventor · disambiguated record
Koyo Matsuda
Also filed as: MATSUDA KOYO
13 granted patents·1 pending application·912 citations·filing 1992–2010
95Inventor score
Top patents by PatentIndex Score
14 records- 0198US7173029B2Fused heteroaryl derivativesIMP CANCER RES TECH·Filed 2005·Granted Feb 6, 2007·93 cites·20 claims
- 0298US7037915B2Fused heteroaryl derivativesIMP CANCER RES TECH·Filed 2004·Granted May 2, 2006·93 cites·11 claims
- 0398US6838457B2Fused heteroaryl derivativesYAMANOUCHI PHARMA CO LTD·Filed 2003·Granted Jan 4, 2005·99 cites·19 claims
- 0498US6608053B2Fused heteroaryl derivativesYAMANOUCHI PHARMA CO LTD·Filed 2001·Granted Aug 19, 2003·188 cites·11 claims
- 0598US6608056B1Fused heteroaryl derivativesYAMANOUCHI PHARMA CO LTD·Filed 2002·Granted Aug 19, 2003·87 cites·9 claims
- 0698US6403588B1Imidazopyridine derivativesYAMANOUCHI PHARMA CO LTD·Filed 2001·Granted Jun 11, 2002·147 cites·12 claims
- 0797US6770641B2Fused heteroaryl derivativesYAMANOUCHI PHARMA CO LTD·Filed 2003·Granted Aug 3, 2004·71 cites·9 claims
- 0896US6653320B2Imidazopyridine derivativesYAMANOUCHI PHARMA CO LTD·Filed 2002·Granted Nov 25, 2003·80 cites·14 claims
- 0994US8067586B2Fused heteroaryl derivativesHAYAKAWA MASAHIKO·Filed 2010·Granted Nov 29, 2011·10 cites·6 claims
- 1066US6300364B1Medicinal compositions with cholesterol-lowering effectYAMANOUCHI PHARMA CO LTD·Filed 1998·Granted Oct 9, 2001·30 cites·4 claims
- 1164US2007037805A1Fused heteroaryl derivativesHAYAKAWA MASAHIKO·Filed 2006·Application pending·0 cites
- 1261US5258405AUrea derivatives and salts thereof in method for inhibiting the ACAT enzymeYAMANOUCHI PHARMA CO LTD·Filed 1992·Granted Nov 2, 1993·6 cites·7 claims
- 1349US5830902AQuinuclidine derivative having tricyclic hetero condensed ringYAMANOUCHI PHARMA CO LTD·Filed 1996·Granted Nov 3, 1998·5 cites·19 claims
- 1448US5420348AUrea derivatives and salts thereofYAMANOUCHI PHARMA CO LTD·Filed 1993·Granted May 30, 1995·3 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Koyo Matsuda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →